US Stocks
/
ImageneBio, Inc. Share Price

ImageneBio, Inc. Share Price

NASDAQ: IMA | Micro Cap
$4.24
+$0.13 (3.04%) Last updated on 10 Oct, 2026 | 01:25 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

ImageneBio, Inc. Stock Performance

Open
$4.20
Prev. Close
$4.12
Circuit Range
N/A
Day Range
$4.20 - $4.20
Year Range
$4.01 - $9.01
Volume
269
Average Traded
$4.20

ImageneBio, Inc. Share Price Today

As of 10 October 2026, ImageneBio, Inc.'s share price is $4.24. The stock opened at $4.20, compared to its previous close of $4.12. During today's trading session, ImageneBio, Inc.'s share price traded between $4.20 and $4.20, with an average price of $4.20. Over the past 52 weeks, the stock has recorded a high of $9.01 and a low of $4.01. In terms of performance, ImageneBio, Inc.'s share price has declined by 29.92% over the last six months and is down 50.64% on a year-on-year basis.

ImageneBio, Inc. Share Price Chart

$4.20$4.20
L
Show Current Price
H

ImageneBio, Inc. Stock Fundamentals & Key Indicators

Market Cap
$20.65M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-4.70
Revenue (TTM)
$800.00M
Return On Equity (TTM)
-37.54%
Profit Margin
-6550.00%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
60.28%

ImageneBio, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$25.63-$6.91-$10.62-$10.18
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A73.04%-53.69%4.14%

ImageneBio, Inc. Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$0.80
Net Profit-$52.40
Net Profit Margin-6550.00%
Income ChangeN/A

About ImageneBio, Inc.

ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.

ImageneBio, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$4.58
$4.20
-15.07%
Sep 2026
$4.96
$4.95
-10.50%
Aug 2026
$5.33
$5.53
-3.07%
Jul 2026
$5.81
$5.70
-6.25%
Jun 2026
$5.56
$6.08
+3.40%
May 2026
$5.89
$5.88
-2.81%
Apr 2026
$4.96
$6.05
+26.30%
Mar 2026
$6.24
$4.79
-31.47%
Feb 2026
$7.23
$6.99
-6.68%
Jan 2026
$6.87
$7.49
+9.02%
Dec 2025
$6.71
$6.87
-3.24%
Nov 2025
$8.30
$7.10
-17.35%

IMA Share Price FAQs

What is ImageneBio, Inc. share price today?

chevron-up
ImageneBio, Inc. share price today is $4.24 as on October 10, 2026 at 1:25 am IST.

What is the 52 week high and 52 week low of ImageneBio, Inc. stock?

chevron-up
The 52 week high of ImageneBio, Inc. stock is $9.01, while the 52 week low is $4.01 as of 10 Oct '26.

What is IMA's market capitalisation today?

chevron-up
IMA market capitalisation is $20.65M as of October 10, 2026, at 8:13 am IST.

What is IMA's net income for the last quarter?

chevron-up
IMA's net income for the last quarter is -10.18B USD.

What is the 5 year returns of IMA?

chevron-up
The 5 year returns of IMA is -72.59% as on 10 Oct '26.

What is the high & low stock price of IMA today?

chevron-up
IMA stock price hit a high of $4.20 and low of $4.20 as of 10 Oct '26.

Can I buy IMA shares in India?

chevron-up
Yes. You can buy IMA in India by opening an international trading account.